Abstract: The present invention relates to novel compounds for the inhibition of cyclin-dependent kinases, and more particularly, to chromenone derivatives of formula (Ic) wherein R1, R2, R3, R4, R5, R6, R7 and A have the meanings indicated in the claims. The invention also relates to processes for the preparation of the compounds of formula (Ia), to methods of inhibiting cyclin-dependent kinases and of inhibiting cell proliferation, to the use of the compounds of formula (Ic) in the treatment and prophylaxis of diseases, which can be treated or prevented by the inhibition of cyclin-dependent kinases such as cancer, to the use of the compounds of formula (Ic) in the preparation of medicaments to be applied in such diseases.

Abstract: This invention relates to copolymer compositions having pigment like properties, comprising a fluorescent or non-fluorescent dye attached to a polymer chain by a spacer having a chain length of C3 or longer. The invention also provides for new mono- and difunctional dye monomers comprising a polymerizable group attached to a dye moiety by a spacer of a chain length of C3 or longer. The polymer pigments provide excellent properties, especially high temperature stability and easy applicability as colorant in different standard polymers.

Abstract: This invention relates to copolymer compositions having pigment like properties, comprising a fluorescent or non-fluorescent dye attached to a polyurea or polyurethane chain by a spacer.

Abstract: An aorta graft device comprising a primary graft part having a proximal end and a first connecting portion at a distal opening, wherein the primary graft part has an anchoring area positioned between an ascending portion extending to said proximal end and a descending portion extending to said distal opening. Furthermore, the ascending portion is corrugated, and the descending portion is at least partially non-corrugated.

Abstract: The epindolidione compounds of the general formula (I) 1

Abstract: The present invention relates to novel compounds for the inhibition of cyclin-dependent kinases, and more particularly, to chromenone derivatives of formula (Ia), 1

Abstract: This invention relates to copolymer compositions having pigment like properties, comprising a fluorescent or non-fluorescent dye attached to a polymer chain by a spacer having a chain length of C3 or longer.

Abstract: Use of the pigment of formula (I) in which X stands for Cl or CH3, and of formula (II) wherein R is phenyl or C12H25, for the coloration of polyolefins which do not warp.

Abstract: The triphendioxazine compounds of the general formula (I) in which the rings labeled A in positions 1,2-, 2,3- or 3,4- and 8,9-, 9,10- or 10,11- carry a linearly or angularly fused heterocyclic ring containing at least one nitrogen atom which is substituted or unsubstituted, with the proviso that compounds with only unsubstituted nitrogen atoms and symmetrically disubstituted compounds with C1-2alkyl and unsubstituted phenyl substituents are excluded, are outstanding pigments and are notable over the closest comparable pigments in particular for better migration, light and solvent fastnesses, better heat stability and enhanced colouring power and also better dispersibility and capability to be brought into pigment form. The invention also relates to a process for preparing these triphendioxazine compounds which is characterized by a cyclization step conducted in the presence of manganese dioxide and concentrated sulphuric acid.

Abstract: Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them. Substituted 1-naphthoylguanidines of the formula I in which R2 to R8 have the meanings indicated in the claims, are suitable as antiarrhythmic pharmaceuticals having a cardioprotective component for infarct prophylaxis and infarct treatment and for the treatment of angina pectoris. They also preventively inhibit the pathophysiological processes in the formation of ischemically induced damage, in particular in the production of ischemically induced cardiac arrhythmias.

Abstract: This invention relates to new fluorescent or non-fluorescent dye compounds having a terminal hydroxy, carboxylic acid/ester or amino group and a process for their preparation. The new fluorescent or non-fluorescent dye compounds are useful as colorants for preparing colored synthetic polymer resins with pigmentary properties, for dyeing or printing homo- or mixed synthetic, semi-synthetic or natural polymers or substrates or for preparing inks. The dye compounds provide excellent properties, especially high temperature stability and easy applicability.

Abstract: Compounds of the formula: where R1, R2, R3, R4, R5, R6, R7, R8, R′5, R′6, R′7, R′8 are hydroxy —NO2, —CN, —CF3, —CONH2, C1-12alkyl, phenyl, naphthyl, phenanthryl, anthryl, R9R10N—, R9—O—or R9—S—, —CONHR10, —CONR9R10 in which R9 and R10 are C1-C6-alkyl, C6-C10-aryl, (C6-C10)-aryl-(C1-C6)-alkyl or (C1-C6)-alkyl-(C6-C10)-aryl, in which the alkyl and/or aryl radicals can optionally be substituted by hydroxyl, C1-C6-alkoxy, C6-C10-aryloxy or halogen; and optionally, two adjacent groups can form an isocyclic or heterocyclic group; are eminently suitable for the mass coloring of polymers, in particular polar polymers, for coloring toners, powders and powder coating materials as well as for coloring ink-jet inks.

Abstract: The invention is directed to carbamate group containing non chloranil based triphendioxazine compounds useful as pigments which are readily convertible into the corresponding triphendioxazine pigments without carbamate.

Abstract: The invention relates to a process for preparing triphendioxazine compounds by cyclizing the intermediates (IV) in the presence of manganese oxide and sulfuric acid to form compounds of the general formula (I) a process for condensing compounds of the general formula (II) with compounds of the general formula (III) to form the chlorine-free intermediates (IV) and also compounds of the general formula (IV).

Abstract: Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.

Abstract: The invention provides hybrid pigments containing: (a) at least one benzimidazolone triphenodioxazine compound of the formula (I)  and (b) at least one pyrrolo-[3,4-c]-pyrrole compound, or (c) at least one thiazine-indigo compound, or (d) at least one quinacridone compound or (e) at least one copper phthalocyanine compound and a process for the preparation of such hybrid pigments and their use for the mass pigmentation of substrates, as colorants in electrophotographic toners and developers, in powders and powder coating materials, in ink-jet inks and in cosmetic compositions.

Abstract: Use of a pigment of the formula (I) wherein R is chloro or methyl as a colourant in plastics materials for food packaging.

Abstract: New heterocyclic compounds are disclosed which are used as intermediates for the preparation of trans-thiazine-indigo pigments which are in part new compounds and can be used for the mass pigmentation of organic substrates. Also disclosed are different environmentally friendly water-based processes for the preparation of the new heterocyclic compounds and the corresponding pigments.

Abstract: An aorta graft device comprising a primary graft part having a proximal end and a first connecting means at a distal opening, wherein the primary graft part has an anchoring area positioned between an ascending portion extending to said proximal end and a descending portion extending to said distal opening. Furthermore, the ascending portion is corrugated, and the descending portion is at least partially non-corrugated.

Abstract: A new polymorphic form of 2,9-dichloroquinacridone having improved pigmentary properties and a method of forming said 2,9-dichloroquinacridone comprising the step of ring closure of appropriately substituted terephthalic acid in sulphuric acid.